FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway

被引:0
作者
Kun Jiang
Li-zhe Xu
Jin-zhuo Ning
Fan Cheng
机构
[1] Renmin Hospital of Wuhan University,Department of Urology
来源
Cancer Cell International | / 23卷
关键词
Clear cell renal cell carcinoma; FAP; Prognostic biomarker; Oncogene; PI3K/AKT/mTOR signaling;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 115 条
[1]  
Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin 68 394-424
[2]  
Miller KD(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 37 498-505
[3]  
Jemal A(2014)State-of-the-art management of renal cell carcinoma Am J Clin Oncol 173 595-3211
[4]  
Bray F(2018)Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal Cell 5 CD011673-19444
[5]  
Ferlay J(2022)SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition Mol Ther Oncolytics 11 3203-272
[6]  
Soerjomataram I(2017)Immunotherapy for metastatic renal cell carcinoma Cochrane Database Syst Rev 280 19441-1813
[7]  
Siegel RL(2015)Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review) Mol Med Rep 12 586-640
[8]  
Torre LA(2005)Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha J Biol Chem 60 264-283
[9]  
Jemal A(2021)Reduced hyaluronan cross-linking induces breast cancer malignancy in a CAF-dependent manner Cell Death Dis 61 1806-e110
[10]  
Mourad WF(2015)Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro Adv Med Sci 9 e88772-658